In Canada, Oligo Medic, a medical device company that develops biomaterials for regenerative medicine and is known for JointRep for cartilage treatment in body joints, has a new CEO, Jerett A. Creed. Creed’s career started with Johnson and Johnson focusing on angioplasty balloons and metal stents, as CFO of a publicly traded oil and gas company and CEO of Cardigant Medical, but has evolved with his 20 years of experience in the medical technology field. Creed led Oligo Medic’s launch of their JointRep product in Latin America. He has also been involved in 2 public offerings as well as more than $650 million merger and acquisition activities for Oligo Medic.
Latest article
Fin-ished, for now: Aqua Cultured Foods shutters as funding dries up
In Chicago, a fermentation startup converting cellulose into seafood alternatives has wound down operations after failing to raise funds necessary to reach commercialization.
Established...
Mercedes unveils vegan-interior SUV at CES
In Nevada, Mercedes-Benz has showcased a new, vegan-interior GLC electronic SUV at the recent CES technology trade show in Las Vegas.
Vegan materials were...
Futerro files permits for French PLA site
In France, biobased chemicals maker Futerro has requested the relevant permits for its planned lactic acid and polylactic acid plant in France.
The plant, which...